Log in
Enquire now

Clinical Studies Sponsored by GlaxoSmithKline

Clinical Studies Sponsored by GlaxoSmithKline
Clinical Studies Sponsored by Biogen
Clinical Studies Sponsored by Celgene
Clinical Studies Sponsored by Shionogi
List of funding rounds for 99.co
List of Walbro patents
Clinical Studies where
Trial Sponsor
is
Name
Description
NCT Number
Health Conditions in Trial
Clinical Trial Start Date
Study Completion Date
Clinical Trial Study Type
‌
Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus

NCT01045590
2003
2006
Interventional
‌
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

NCT01381523
2010
2011
Observational
‌
WEUSKOP5410: Observational Study in ENABLE Clinical Trials

NCT01458080
Hepatitis C
Hepatitis C
2011
2013
Observational
‌
A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

NCT01597648
2011
2012
Interventional
‌
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

NCT01381497
2010
2011
Observational
‌
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

NCT01390909
Epilepsy
Epilepsy
2010
2011
Observational
‌
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic

NCT00244686
‌
Hypereosinophilic syndrome
‌
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

NCT01445587
Cancer
Cancer
2011
2011
Interventional
‌
WEUSKOP6166: Lamotrigine and Aseptic Meningitis

NCT01657864
Epilepsy
Epilepsy
2012
2012
Observational
‌
Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim

NCT01439321
Immune thrombocytopenic purpura
Immune thrombocytopenic purpura
2010
2011
Observational
‌
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation

NCT00421720
‌
Sedation
‌
Analgesia
2007
Interventional
‌
Aura Adolescent PK Study GSK2829332

NCT01653483
Asthma
Asthma
2012
2013
Interventional
‌
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting

NCT01013948
2009
2009
Observational
‌
Fosamprenavir in Pts With Hepatic Impairment

NCT01054586
2009
2012
Observational
‌
A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women

NCT00388596
Osteoporosis
Osteoporosis
2006
Interventional
‌
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

NCT01431924
Asthma
Asthma
2010
2012
Observational
‌
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

NCT01381614
2011
2011
Observational
‌
Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

NCT06577597
September 2, 2024
October 23, 2024
Interventional
‌
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV

NCT00527826
2007
2009
Interventional
‌
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

NCT01381601
2011
2011
Observational
‌
Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer

NCT01231581
Cancer
Cancer
2010
2013
Interventional
‌
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

NCT01587339
Epilepsy
Epilepsy
2010
2011
Observational
‌
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

NCT00086658
‌
Hypereosinophilic syndrome
‌
Hypereosinophilia
March 23, 2004
May 1, 2006
Interventional
‌
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

NCT00370227
2006
2007
Interventional
‌
SD Cystic Fibrosis Study

NCT00605761
Cystic fibrosis
Cystic fibrosis
2008
2008
Interventional
...
Results per page:
3,243 results
0 selected
3,243 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us